Tom Cohen

MSD to Acquire Bispecific Antibody From Curon in Bid to Diversify Portfolio

—

by

Tom Cohen
in

The novel investigational clinical stage bispecific antibody targets CD3xCD19 to engage T cells with malignant B cells.

Read More

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *